发明名称 |
Lipid dispersions and methods of use |
摘要 |
Methods for preventing or ameliorating the transient adverse physiological response to particulate dispersions (TAPR response) when these dispersions are administered parenterally to a patient. The methods comprise the administration of a prophylactic anti-inflammatory drug prior to administration of the particulate-containing material, and optionally during administration as well. Preferred drugs are cyclooxygenase inhibitors and corticosteroids.
|
申请公布号 |
US6361792(B1) |
申请公布日期 |
2002.03.26 |
申请号 |
US19980206805 |
申请日期 |
1998.12.07 |
申请人 |
ALLIANCE PHARMACEUTICAL CORP. |
发明人 |
LONG, JR. DAVID M. |
分类号 |
A61K9/00;A61K31/02;A61K31/19;A61K31/405;A61K31/415;A61K31/44;A61K31/57;A61K31/60;A61K47/18;A61K49/04;(IPC1-7):A61K9/127;A61K51/00;A61K31/50 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|